FUNDAMENTALS · Fundamentals · India Healthcare

FDC (FDC) Fundamentals 2026 — P/E 23.7x, Revenue Analysis | SniperIQ

FDC (FDC) is a India-listed Healthcare company in Medical - Pharmaceuticals with a market capitalization of ₹6,665 Crore, trading at ₹409.80 on the BSE. This SniperIQ fundamentals page covers FDC's valuation (P/E 23.7x, P/B 2.7x), profitability (net margin 13.0%), revenue (₹2,171 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap₹6,665 Crore
P/E (TTM)23.7x
Net Margin13.0%
Revenue (FY26)₹2,171 Crore

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is FDC's market cap?

FDC (FDC) has a market capitalization of approximately ₹6,665 Crore, trading at ₹409.80 on the BSE. Market cap moves with the live share price.

What is FDC's P/E ratio?

FDC's trailing twelve-month P/E ratio is 23.7x, with a price-to-book (P/B) of 2.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is FDC?

FDC runs a net profit margin of 13.0%, a gross margin of 55.3%, and an operating margin of 13.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does FDC generate?

FDC reported revenue of ₹2,171 Crore for fiscal year 2026, with net income of ₹281 Crore and earnings per share (EPS) of 17.29. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does FDC pay a dividend?

FDC offers a trailing dividend yield of about 1.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is FDC financially healthy?

FDC carries a debt-to-equity ratio of 0.01x and a current ratio of 3.11x, with a market beta of 0.18. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is FDC a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For FDC (FDC) the key facts are: market cap ₹6,665 Crore, P/E 23.7x, revenue ₹2,171 Crore, 52-week range 314.75-528.3. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track FDC's full fundamentals live

Get FDC's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: KYORIN Holdings (4569) fundamentals · Amicogen (092040) fundamentals · Regeneron Pharmaceuticals (REGN) fundamentals · Encell (456070) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons